14. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating
atopic dermatitis. J Am Acad Dermatol 2002;46(2):228-241.
15. Misseghers BS, Binnington AG, Mathews KA. Clinical observations of the treatment of canine perianal fistulas with topical
tacrolimus in 10 dogs. Can Vet J 2000;41(8):623-627.
16. Marsella R, Nicklin CF, Saglio S, et al. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic)
in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Vet Dermatol 2004;15(5):294-303.
17. Bensignor E, Olivry T. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized
controlled trial. Vet Dermatol 2005;16(1):52-60.
18. Griffies JD, Mendelsohn CL, Rosenkrantz WS. Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and
pemphigus erythematosus in dogs. J Am Anim Hosp Assoc 2004;40(1):29-41.
19. Meingassner JG, Fahrngruber H, Bavandi A. Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization
phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A. J Invest Dermatol 2003;121(1):77-80.
20. Cummins JM, Krakowka GS, Thompson CG. Systemic effects of interferons after oral administration in animals and humans. Am J Vet Res 2005;66(1):164-176.
21. Stokking LB, Ehrhart EJ, Lichtensteiger CA, et al. Pigmented epidermal plaques in three dogs. J Am Anim Hosp Assoc 2004;40(5):411-417.
22. Thompson LA, Grieshaber TL, Glickman L, et al. Human recombinant interferonalpha-2b for management of idiopathic recurrent
superficial pyoderma in dogs: a pilot study. Vet Ther 2004;5(1):75-81.
23. Martin V, Najbar W, Gueguen S, et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled
challenge trial. Vet Microbiol 2002;89(2-3):115-127.
24. de Mari K, Maynard L, Eun HM, et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled
field trial. Vet Rec 2003;152(4):105-108.
25. de Mari K, Maynard L, Sanquer A, et al. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus
(FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J Vet Intern Med 2004;18(4):477-482.
26. Southerden P, Gorrel C. Treatment of a case of refractory feline chronic gingivostomatitis with feline recombinant interferon
omega. J Small Anim Pract 2007;48(2):104-106.
27. Carlotti D, Madiot G, et al. Use of recombinant omega interferon therapy in canine atopic dermatitis: a pilot study. Vet Dermatol 2004;15(s):32.
28. Gutzwiller ME, Brachelente C, Taglinger K, et al. Feline herpes dermatitis treated with interferon omega. Vet Dermatol 2007;18(1):50-54.
29. Iwasaki T, Hasegawa A. A randomized comparative clinical trial of recombinant canine interferon-gamma (KT-100) in atopic
dogs using antihistamine as control. Vet Dermatol 2006;17(3):195-200.
|
Featuring Information from:
Sponsored by:
